These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 460433)

  • 21. Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies.
    Hocart SJ; Reddy V; Murphy WA; Coy DH
    J Med Chem; 1995 May; 38(11):1974-89. PubMed ID: 7783129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.
    Efendić S; Lins PE; Luft R; Sievertsson H; Westin-Sjödal G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):579-86. PubMed ID: 194446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 24. Extrahypophyseal effects of somatostatin.
    Efendić S; Lins PE; Uvnäs-Wallensten K
    Ann Clin Res; 1978; 10(3):151-6. PubMed ID: 363038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure activity studies on somatostatin.
    Sarantakis D; McKinley WA; Jaunakais I; Clark D; Grant NH
    Clin Endocrinol (Oxf); 1976; 5 Suppl():275S-278S. PubMed ID: 1052780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin and the gastrointestinal secretions.
    Konturek SJ
    Scand J Gastroenterol; 1976; 11(1):1-4. PubMed ID: 766152
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.
    Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gastric acid secretion by somatostatin and analogs in the rat.
    Lippmann W; Borella LE
    Pharmacol Res Commun; 1976 Oct; 8(5):445-54. PubMed ID: 1026967
    [No Abstract]   [Full Text] [Related]  

  • 30. Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography.
    Meyers CA; Coy DH; Huang WY; Schally AV; Redding TW
    Biochemistry; 1978 Jun; 17(12):2326-31. PubMed ID: 678512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrin release and HCl secretion induced by electrical vagal stimulation in the cat.
    Uvnäs-Wallensten K
    Acta Physiol Scand Suppl; 1976; 438():1-39. PubMed ID: 1067741
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of somatostatin receptors involved in inhibition of gastric acid and growth hormone secretion with halogenated Trp8 analogues [proceedings].
    Coy DH; Hirst BH; Meyers CA; Reed JD; Schally AV
    J Physiol; 1978 Dec; 285():40P. PubMed ID: 217989
    [No Abstract]   [Full Text] [Related]  

  • 36. Somatostatin analogs with improved oral bioavailability.
    Nutt RF; Colton CD; Veber DF; Slater EL; Saperstein R
    Klin Wochenschr; 1986; 64 Suppl 7():71-3. PubMed ID: 2882053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.
    Barros D'sa AA; Bloom SR; Baron JH
    Gut; 1978 Apr; 19(4):315-20. PubMed ID: 348581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analogs of somatostatin. Part A. Chemistry and in vitro results.
    Immer H; Abraham NA; Nelson V; Sestanj K; Götz M; Brazeau P; Martin JB
    Curr Top Mol Endocrinol; 1976; 3():373-8. PubMed ID: 1052675
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin.
    Cabranes JA; Vela A; Timoneda F; Meyers CA; Coy DH; Schally AV; Charro AL
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):421-31. PubMed ID: 6150528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin, basic and clinical studies. A review.
    Schally AV; Meyers CA
    Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.